A Double-blind Randomized Parallel Group Study of Three Cumulative Doses of Grass MATA MPL Compared to Placebo and Grass MATA in Patients With Seasonal Allergic Rhinoconjunctivitis Exposed to Grass Pollen in Mobile Environmental Exposure Chambers (mEECs) Out of the Grass Pollen Season

Trial Profile

A Double-blind Randomized Parallel Group Study of Three Cumulative Doses of Grass MATA MPL Compared to Placebo and Grass MATA in Patients With Seasonal Allergic Rhinoconjunctivitis Exposed to Grass Pollen in Mobile Environmental Exposure Chambers (mEECs) Out of the Grass Pollen Season

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Allergy immunotherapy (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Allergy Therapeutics
  • Most Recent Events

    • 08 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Apr 2017.
    • 27 Jun 2016 Results published in an Allergy Therapeutics media release.
    • 18 Mar 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top